Glaxosmi. Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE159A01016
NSEID: GLAXO
BSEID: 500660
View on NSE | View on BSE

INR

2,655.40

44.7 (1.71%)

BSENSE

Jul 31, 03:59 PM

BSE+NSE Vol: 1.21 lacs

{
  "main_header": {
    "sid": 793005,
    "name": "Glaxosmi. Pharma",
    "stock_name": "Glaxosmi. Pharma",
    "full_name": "Glaxosmithkline Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/glaxosmi-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,655.40",
    "chg": 44.7,
    "chgp": "1.71%",
    "dir": 1,
    "prev_price": "2,610.70",
    "mcapval": "44,042.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500660,
    "symbol": "GLAXO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE159A01016",
    "curr_date": "Jul 31, 03:59 PM",
    "curr_time": "16:59 PM",
    "last_traded_at": "Jul 31, 03:59 PM IST",
    "bse_nse_vol": "1.21 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glaxosmi-pharma-793005-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-4127896",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Glaxosmithkline_technicaldot_4127896.png",
        "date": "2026-07-30 08:02:01",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent performance and underlying metrics suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-4125107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Glaxosmithkline_technicaldot_4125107.png",
        "date": "2026-07-29 08:02:48",
        "description": "Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a strong day change of 3.57%, the stock’s technical indicators reveal a transition from a mildly bearish trend to a sideways momentum, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4124225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Glaxosmithkline_mojoScore_4124225.png",
        "date": "2026-07-28 10:10:03",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4106335",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Glaxosmithkline_mojoScore_4106335.png",
        "date": "2026-07-17 10:10:04",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are current as of 17 July 2026, providing investors with an up-to-date view of the company’s performance and valuation."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4090728",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Glaxosmithkline_mojoScore_4090728.png",
        "date": "2026-07-06 10:10:05",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4073159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_mojoScore_4073159.png",
        "date": "2026-06-25 10:10:05",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4068106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_technicaldot_4068106.png",
        "date": "2026-06-23 08:05:20",
        "description": "Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish stance as of late June 2026. Despite a modest day gain of 1.40%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, contextualising them within the broader market and sector trends to provide investors with a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-sell-4052873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/Glaxosmithkline_mojoScore_4052873.png",
        "date": "2026-06-14 10:10:04",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Drops 1.92%: Bearish Momentum and 52-Week Lows Define Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-drops-192-bearish-momentum-and-52-week-lows-define-week-4052222",
        "imagepath": "",
        "date": "2026-06-13 17:08:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock hits 52-week low of Rs.2,184 amid technical downgrade</p>\n                    <p><strong>2 June:</strong> New 52-week low recorded at Rs.2,166.6</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.2,166.30, down 1.92% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,208.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,166.30</div><div class=\"stat-change negative\">-1.92%</div></div>\n                    <div class=\"stat-item\"..."
      }
    ],
    "total": 5203,
    "sid": "793005",
    "stock_news_url": "https://www.marketsmojo.com/news/glaxosmithkline-pharmaceuticals-793005"
  },
  "announcements": [
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Change of name of Registrar and Transfer Agent'.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Submission of Disclosure on Related Party Transactions '.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "30-Oct-2019"
    },
    {
      "details": "GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Results publication '.",
      "source": "NSE",
      "caption": "GlaxoSmithKline Pharmaceuticals Limited - Updates",
      "datetime": "23-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "03 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has declared <strong>570%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Sep 18",
          "dt": "2018-09-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-07-30 08:02:01

Glaxosmithkline Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent performance and underlying metrics suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-07-29 08:02:48

Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a strong day change of 3.57%, the stock’s technical indicators reveal a transition from a mildly bearish trend to a sideways momentum, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-07-28 10:10:03

Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-07-17 10:10:04

Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are current as of 17 July 2026, providing investors with an up-to-date view of the company’s performance and valuation.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-07-06 10:10:05

Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-06-25 10:10:05

Glaxosmithkline Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Oct 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 25 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-23 08:05:20

Glaxosmithkline Pharmaceuticals Ltd (NSE: 793005) has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish stance as of late June 2026. Despite a modest day gain of 1.40%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, contextualising them within the broader market and sector trends to provide investors with a comprehensive view of the stock’s current positioning.

Read full news article

Glaxosmithkline Pharmaceuticals Ltd is Rated Sell

2026-06-14 10:10:04

Glaxosmithkline Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.